Skp to main content
Home

Main navigation

  • Innovation

        Innovation

      • Overview
      • Capabilities
      • Innovation is
      • Pipeline
      • Drug discovery
      • Clinical studies
      • Publications

      You might be interested in...

      Hypothesize That logo
      Page

      Hypothesize That! Discover our new science podcast, where science meets conjecture and curiosity

      Page

      Publications - A dedicated space where we share a collection of our scientific peer-reviewed...

      Page

      Pipeline - Check out our clinical development pipeline spanning several therapy areas

  • Solutions

        Solutions

      • Overview
      • Healthcare professionals
      • Diseases
      • Medicines

      You might be interested in...

      Page

      Hidradenitis Suppurativa – Learn more about Hidradenitis Suppurativa an inflammatory skin disease

      Page

      WoCBA - Closing the gaps in research in the care of women of childbearing age with chronic diseases

      Page

      Clinical studies – Click to find out more on our clinical studies

  • About UCB

        About UCB

      • Overview
      • Management
      • Sustainability
      • Our positions
      • Ethics & Business Integrity
      • Collaborate with us

      You might be interested in...

      Page

      Integrated Annual Report 2024 - Click here to access the report

      Page

      UCBCares® - Discover what UCBCares® is about and the services they offer

      Picture of the Arkelia building on the Braine-l'Alleud campus in Belgium
      Story
      10 Feb 2025

      Driving innovation forward: UCB unveils new R&D facility

  • Newsroom

        Newsroom

      • Overview
      • Press releases
      • Our stories
      • Resources
      • Contact details

      You might be interested in...

      Press releases teaser image
      Press Release
      11 Apr 2025

      Global data show real-world effectiveness of romosozumab for patients at high fracture risk

      Press releases teaser image
      Press Release
      7 Mar 2025

      BIMZELX[®] (bimekizumab-bkzx) five-year data at AAD 2025 showed sustained skin clearance and long...

      Press releases teaser image
      Press Release
      27 Feb 2025

      On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth

  • Investors

        Investors

      • Overview
      • Equity Story
      • Performance
      • Corporate governance
      • Shareholders
      • Download center

      You might be interested in...

      Press releases teaser image
      Press Release
      27 Feb 2025

      On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth

      Press Release
      5 Nov 2024

      UCB completes sale of established brands and updates 2024 financial guidance

      Page

      Download center – Click here to view a collection of useful documents

  • Careers
  • Go to global site 
Country Navigator

Wendy

Listen

You are here

  • Home
  • Patients
  • Life Stories
  • Wendy

Spotlight on Wendy (The Netherlands)

 

  • Born in 1966
  • Living with lupus
  • Speaks Dutch & English
  • Loves riding horses
  • Works in husband’s tax advisory firm  


For years and years, Wendy dealt with symptoms without an explanation. Every time she had a baby, she’d develop a rash and joint pain that lasted for months. Then, six months after her youngest child was born, Wendy’s mother suggested she see a rheumatologist. Initially, she was diagnosed with fibromyalgia. Although she didn’t think that was accurate, Wendy convinced herself that there was nothing physically wrong with her, and that she’d always have some pain.


Ten years later, after falling from her horse, Wendy again made a trip to the doctor. She hadn’t broken anything, but was experiencing intense pain and numbness. It was at this point that she learned the ANA test she’d had a decade before showed positive results. She had lupus.


Wendy went on to find a rheumatologist she worked well with. And after she had trouble tolerating the initial treatments she was prescribed, Wendy and her doctor came up with a new plan together. Today, Wendy is still learning to adjust to a life with lupus. She’s realized that there are good days and bad days, so she knows it’s important to ask for support when she needs it. She has dedicated herself to increasing awareness and education for autoimmune diseases, and she hopes that doctors and researchers will continue to search for more treatment options.

 

When you live with an autoimmune disorder like lupus, time is so important. We must make the most of now. So I’m doing my part. I hope to inspire others to make a difference for lupus patients.

Wendy

Back to life stories page

Choose a Country

  • Global Site – English
  • Australia – English
  • België – Engels
  • Belgique – Anglais
  • Brasil – Português
  • България – Български
  • Canada – English
  • Canada – Français
  • 中国 – 中文
  • Česká Republika – Angličtina
  • Danmark – Engelsk
  • Deutschland – Deutsch
  • France – Français
  • España – Español
  • Ελλάδα – Ελληνικά
  • India – English
  • Ireland – English
  • Italia – Inglese
  • 日本 – 日本語
  • 한국 – 한국어
  • Luxembourg – Anglais
  • Luxemburg – Engels
  • Magyarország – Angol
  • México & Latinoamérica – Español
  • Nederland – Engels
  • New Zealand – English
  • Norge – Engelsk
  • Österreich – Deutsch
  • Polska – Polski
  • Portugal – español y portugués
  • România – Engleză
  • Россия – Русский
  • Slovensko – Anglický
  • Suomi – Englanti
  • Sverige – Engelska
  • Schweiz – Deutsch
  • Suisse – Français
  • Türkiye – Türkçe
  • Україна – Англійська
  • United Kingdom – English
  • U.S.A. – English

© 2007 - 2025 UCB S.A., Belgium. All rights reserved. Last updated on: January, 03, 2024

Social media links

  • linkedin
  • instagram
  • facebook
  • twitter
  • youtube

Footer menu

  • Contact us
  • UCBCares®
  • UCB Worldwide
  • Legal Notice
  • Privacy policies
  • Cookie policies
  • Cookie preferences
  • Payment disclosure
  • Sitemap

© 2007 - 2025 UCB S.A., Belgium. All rights reserved. Last updated on: January, 27, 2025